EDP-1867

N/A

Report date: 2023/01/01 08:32:09

Base Information

Drug NameEDP-1867
Drug Alias NameEDP-1867EDP 1867EDP1867 (Veillonella parvula)
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsPsoriasisDermatitis, AtopicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEvelo Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEvelo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis, AtopicAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A